Results 221 to 230 of about 310,818 (241)
Some of the next articles are maybe not open access.
American Journal of Ophthalmology, 1979
A 71-year-old woman had a history of recent weight loss and bilateral decreased visual acuity, bilateral serous detachment, and mental depression. Fluorescein angiograms showed a myriad of retinal pigment epithelial leakage points. Despite extensive evaluation, the cause of her weight loss and ocular process remained uncertain until her death, when ...
Marilyn C. Kincaid+2 more
openaire +3 more sources
A 71-year-old woman had a history of recent weight loss and bilateral decreased visual acuity, bilateral serous detachment, and mental depression. Fluorescein angiograms showed a myriad of retinal pigment epithelial leakage points. Despite extensive evaluation, the cause of her weight loss and ocular process remained uncertain until her death, when ...
Marilyn C. Kincaid+2 more
openaire +3 more sources
Annals of Internal Medicine, 1968
Excerpt I would rather learn from one bird how to sing than teach ten thousand stars how not to dance. e. e.
openaire +3 more sources
Excerpt I would rather learn from one bird how to sing than teach ten thousand stars how not to dance. e. e.
openaire +3 more sources
European Journal of Haematology, 2001
Abstract: Acute basophilic leukemia has recently been included into a revised classification of acute leukemias proposed by the WHO panel. Due to the rarity of the disease, consistent diagnostic criteria are lacking. We report on two cases of acute basophilic leukemia that occurred in our department during the last 10 yr.
Manuel Aivado+5 more
openaire +3 more sources
Abstract: Acute basophilic leukemia has recently been included into a revised classification of acute leukemias proposed by the WHO panel. Due to the rarity of the disease, consistent diagnostic criteria are lacking. We report on two cases of acute basophilic leukemia that occurred in our department during the last 10 yr.
Manuel Aivado+5 more
openaire +3 more sources
AJN, American Journal of Nursing, 1975
One of the most encouraging endeavors in pediatric oncology in recent years has been the development of treatment regimens for acute lymphoblastic leukemia. Remission in children with leukemia was first induced with aminopterin in 1948(1). Since then, other drugs have been used in numerous combinations.
openaire +3 more sources
One of the most encouraging endeavors in pediatric oncology in recent years has been the development of treatment regimens for acute lymphoblastic leukemia. Remission in children with leukemia was first induced with aminopterin in 1948(1). Since then, other drugs have been used in numerous combinations.
openaire +3 more sources
Archives of Internal Medicine, 1976
The difference between the chemotherapeutic response in patients with acute myelocytic leukemia (AML) and in those with acute lymphocytic leukemia (ALL) would appear to be more a problem of lack of regeneration of normal myeloid tissues than a lack of susceptibility of the neoplastic cell to chemotherapy.
Wallace Hj+10 more
openaire +3 more sources
The difference between the chemotherapeutic response in patients with acute myelocytic leukemia (AML) and in those with acute lymphocytic leukemia (ALL) would appear to be more a problem of lack of regeneration of normal myeloid tissues than a lack of susceptibility of the neoplastic cell to chemotherapy.
Wallace Hj+10 more
openaire +3 more sources
Journal of Pediatric Hematology/Oncology, 1995
Significant advances have occurred in the diagnosis, treatment, and long-term outcome of patients with acute promyelocytic leukemia (APL). The purpose of this review is to describe the molecular genetics of this disease, the use of all-trans retinoic acid (ATRA) in clinical trials of APL, and the clinical and basic research questions for future ...
David Eilender+6 more
openaire +3 more sources
Significant advances have occurred in the diagnosis, treatment, and long-term outcome of patients with acute promyelocytic leukemia (APL). The purpose of this review is to describe the molecular genetics of this disease, the use of all-trans retinoic acid (ATRA) in clinical trials of APL, and the clinical and basic research questions for future ...
David Eilender+6 more
openaire +3 more sources
American Journal of Hematology, 1979
AbstractAcute promyelocytic leukemia (APL) is characterized by proliferation of morphologically abnormal promyelocytes and a severe bleeding diathesis. The abnormal promyelocyte is characterized by abundant, large granules, many of which are spindle‐shaped. Electron microscopic appearance of the granules closely resembles that of Auer rods.
Jerome E. Groopman, Leonard Ellman
openaire +2 more sources
AbstractAcute promyelocytic leukemia (APL) is characterized by proliferation of morphologically abnormal promyelocytes and a severe bleeding diathesis. The abnormal promyelocyte is characterized by abundant, large granules, many of which are spindle‐shaped. Electron microscopic appearance of the granules closely resembles that of Auer rods.
Jerome E. Groopman, Leonard Ellman
openaire +2 more sources
Pediatric Annals, 1983
During the past decade progress in the treatment of childhood acute lymphoblastic leukemia has slowed. A 50% to 60% cure barrier has frustrated a multitudinous array of therapeutic attempts to overcome this obstacle. With few exceptions, intensifications of induction, consolidation, or maintenance therapies have not overcome this obstacle.
openaire +2 more sources
During the past decade progress in the treatment of childhood acute lymphoblastic leukemia has slowed. A 50% to 60% cure barrier has frustrated a multitudinous array of therapeutic attempts to overcome this obstacle. With few exceptions, intensifications of induction, consolidation, or maintenance therapies have not overcome this obstacle.
openaire +2 more sources
Current Problems in Cancer, 1997
Untreated acute leukemia is a uniformly fatal disease with a median survival time shorter than 3 months. Current treatment strategies provide a significant increase in survival time for most patients, some of whom may be cured. The majority of patients with acute leukemia, however, ultimately die of the disease or complications of treatment.
openaire +3 more sources
Untreated acute leukemia is a uniformly fatal disease with a median survival time shorter than 3 months. Current treatment strategies provide a significant increase in survival time for most patients, some of whom may be cured. The majority of patients with acute leukemia, however, ultimately die of the disease or complications of treatment.
openaire +3 more sources